Dr. Mazen Iskandar Publishes Article Titled, “Hernia During 13-03-2023, 10:47

Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical development stage, highly selective third generation RXR nuclear receptor agonist compound, supporting its potential use for prevention and treatment of normal 10-07-2024, 07:00

Mindspa technology officially proven to reduce stress 15-03-2023, 02:06